SEC Company Response from CLOVER HEALTH INVESTMENTS, (CLOV) — Mar 12, 2020
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) (CIK 0001801170)
Date: March 12, 2020 · CIK: 0001801170 · Accession: 0001104659-20-032306
AI Filing Summary & Sentiment
File numbers found in text: 333-236776
Show Raw Text
CORRESP
1
filename1.htm
March 12, 2020
VIA EDGAR
Pam Howell
Special Counsel
Office of Real Estate & Construction
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attn: Pam Howell
Special Counsel
Office of Real Estate & Construction
Re: Social Capital Hedosophia Holdings Corp. III
Registration Statement on Form S-1
Filed February 28, 2020, as amended
File No. 333-236776
Dear Ms. Howell:
Pursuant to Rule 461 of the General Rules and Regulations under
the Securities Act of 1933, as amended (the “Act”), the undersigned hereby joins in the request of Social Capital Hedosophia
Holdings Corp. III that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to
become effective at 4:00 p.m. Washington D.C. time on March 16, 2020, or as soon thereafter as practicable.
Pursuant to Rule 460 of the General Rules and Regulations under
the Act, the undersigned advises that as of the date hereof, the undersigned expects to distribute approximately 1,000 copies of
the Preliminary Prospectus dated March 10, 2020 to prospective underwriters and dealers, institutional investors, retail investors
and others.
The undersigned advises that it has complied and will continue
to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature page follows]
Very truly yours,
CREDIT SUISSE SECURITIES (USA) LLC
By:
/s/ Jesse Chasse
Name: Jesse Chasse
Title: Director
[Signature Page to Underwriter Acceleration
Request Letter]